This trial is completed!
Search for a recruiting clinical trial for your condition
Back to search
You can access this
clinical trial
if you have
Diabetes, Gestational or Glucose Metabolism Disorders
and you are
between 18 and 40
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to evaluate the feasibility of using a quantitative EEG method to evaluate neurodevelopment in newborns and to evaluate whether subtle neurodevelopmental deficits can be detected in newborns from mothers with gestational diabetes mellitus (GDM) compared to control newborns. The second purpose of this study is to determine whether cord blood concentration in docosahexaenoic acid (DHA), an omega-3 fatty acid, is similar in neonates of well-controlled mothers with gestational diabetes mellitus (GDM) compared to control mothers, and to evaluate whether this contributes to neonates neurodevelopment status.
Tris trial is registered with FDA with number: NCT02779452. The sponsor of the trial is Université de Sherbrooke and it is looking for 46 volunteers for the current phase.
Official trial title:
Does Brain Functions Depend on Omega 3 Transferred to the Fetus During the Intra Uterine Life ?